References
- 1. Wolberg AS, Rosendaal FR, Weitz JI, et al. Venous thrombosis. Nat Rev Dis Primers. 2015;1:15006. doi: 10.1038/nrdp.2015.6.27189130
- 2. García-Sanz MT, Pena-Álvarez C, López-Landeiro P, Bermo-Domínguez A, Fontúrbel T, González-Barcala FJ. Symptoms, location and prognosis of pulmonary embolism. Revista Portuguesa de Pneumologia (English Edition). 2014;20:194-199. doi: 10.1016/j.rppnen.2014.06.002.
- 3. Cohen A, Agnelli G, Anderson F, et al. Venous thromboembolism (VTE) in Europe: The number of VTE events and associated morbidity and mortality. Thromb Haemost. 2007;98:756-764. doi: 10.1160/TH07-03-0212.
- 4. Keser G. Inflammation-Induced Thrombosis: Mechanisms, Disease Associations and Management. CPD. 2012;18:1478-1493. doi: 10.2174/138161212799504731.22364132
- 5. Ethier JL, Desautels D, Templeton A, Shah PS, Amir E. Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis. Breast Cancer Res. 2017;19:2. doi: 10.1186/s13058-016-0794-1.521732628057046
- 6. Parlar H, Şaşkın H. Are Pre and Postoperative Platelet to Lymphocyte Ratio and Neutrophil to Lymphocyte Ratio Associated with Early Postoperative AKI Following CABG. Braz J Cardiovasc Surg. 2018;33:233-241. doi: 10.21470/1678-9741-2017-0164.608913230043915
- 7. Chen W, Yang J, Li B, et al. Neutrophil to Lymphocyte Ratio as a Novel Predictor of Outcome in Patients With Severe Traumatic Brain Injury. Journal of Head Trauma Rehabilitation. 2018;33:E53-E59. doi: 10.1097/HTR.0000000000000320.28520670
- 8. Dong CH, Wang ZM, Chen SY. Neutrophil to lymphocyte ratio predict mortality and major adverse cardiac events in acute coronary syndrome: A systematic review and meta-analysis. Clinical Biochemistry. 2018;52:131-136. doi: 10.1016/j.clinbiochem.2017.11.008.29132766
- 9. Guo W, Lu X, Liu Q, et al. Prognostic value of neutrophilto-lymphocyte ratio and platelet-to-lymphocyte ratio for breast cancer patients: An updated meta-analysis of 17079 individuals. Cancer Med. 2019;8:4135-4148. doi: 10.1002/cam4.2281.667572231197958
- 10. Angkananard T, Anothaisintawee T, McEvoy M, Attia J, Thakkinstian A. Neutrophil Lymphocyte Ratio and Cardiovascular Disease Risk: A Systematic Review and Meta-Analysis. BioMed Research International. 2018;2018:1-11. doi: 10.1155/2018/2703518.625224030534554
- 11. Benlice C, Onder A, Babazade R, et al. Is the Neutrophil-to-Lymphocyte Ratio Associated With Increased Morbidity After Colorectal Surgery? Surg Laparosc Endosc Percutan Tech. 2019;29:36-39. doi: 10.1097/SLE.0000000000000588.30358649
- 12. Balta S. Mean Platelet Volume, Neutrophil-Lymphocyte Ratio, and Long-Term Major Cardiovascular Events. Angiology. 2019;70:289-290. doi: 10.1177/0003319718770040.29656655
- 13. Tan TP, Arekapudi A, Metha J, Prasad A, Venkatraghavan L. Neutrophil-lymphocyte ratio as predictor of mortality and morbidity in cardiovascular surgery: a systematic review. ANZ J Surg. 2015;85:414-419. doi: 10.1111/ans.13036.25781147
- 14. Appleton ND, Bailey DM, Morris-Stiff G, Lewis MH. Neutrophil to lymphocyte ratio predicts perioperative mortality following open elective repair of abdominal aortic aneurysms. Vasc Endovascular Surg. 2014;48:311-316. doi: 10.1177/1538574413519713.24464606
- 15. Bhutta H, Agha R, Wong J, Tang TY, Wilson YG, Walsh SR. Neutrophil-Lymphocyte Ratio Predicts Medium-Term Survival Following Elective Major Vascular Surgery: A Cross-Sectional Study. Vasc Endovascular Surg. 2011;45:227-231. doi: 10.1177/1538574410396590.21289130
- 16. Sbarouni E, Georgiadou P, Kosmas E, Analitis A, Voudris V. Platelet to lymphocyte ratio in acute aortic dissection. J Clin Lab Anal. 2018;32:e22447. doi: 10.1002/jcla.22447.681691529603401
- 17. Bath J, Smith JB, Kruse RL, Vogel TR. Association of neutrophil-to-lymphocyte ratio with outcomes after elective abdominal aortic aneurysm repair. Journal of Vascular Nursing. 2019;37:213-220. doi: 10.1016/j.jvn.2019.06.001.689216931727313
- 18. Russu E, Mureșan AV, Arbănași EM, et al. The Predictive Role of NLR and PLR in Outcome and Patency of Lower Limb Revascularization in Patients with Femoropopliteal Disease. Journal of Clinical Medicine. 2022;11:2620. doi: 10.3390/jcm11092620.910310435566745
- 19. Mureșan AV, Russu E, Arbănași EM, et al. Negative Impact of the COVID-19 Pandemic on Kidney Disease Management—A Single-Center Experience in Romania. Journal of Clinical Medicine. 2022;11:2452. doi: 10.3390/jcm11092452.910427835566576
- 20. Mureșan AV, Russu E, Arbănași EM, et al. The Predictive Value of NLR, MLR, and PLR in the Outcome of End-Stage Kidney Disease Patients. Biomedicines. 2022;10:1272. doi: 10.3390/biomedicines10061272.922015935740294
- 21. Arbănași EM, Mureșan AV, Coșarcă CM, et al. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Impact on Predicting Outcomes in Patients with Acute Limb Ischemia. Life. 2022;12:822. doi: 10.3390/life12060822.922556535743853
- 22. Wang Q, Ma J, Jiang Z, Ming L. Prognostic value of neutrophilto-lymphocyte ratio and platelet-to-lymphocyte ratio in acute pulmonary embolism: a systematic review and meta-analysis. Int Angiol. 2018;37:4-11. doi: 10.23736/S0392-9590.17.03848-2.28541022
- 23. Durmus E, Kivrak T, Gerin F, Sunbul M, Sari I, Erdogan O. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio are Predictors of Heart Failure. Arq Bras Cardiol. 2015;105:606-613. doi: 10.5935/abc.20150126.469366526536980
- 24. Kayrak M, Erdoğan Hİ, Solak Y, et al. Prognostic Value of Neutrophil to Lymphocyte Ratio in Patients with Acute Pulmonary Embolism: A Restrospective Study. Heart, Lung and Circulation. 2014;23:56-62. doi: 10.1016/j.hlc.2013.06.004.23856365
- 25. Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71.800592433782057
- 26. Karataş MB, İpek G, Onuk T, et al. Assessment of Prognostic Value of Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio in Patients with Pulmonary Embolism. Acta Cardiol Sin. 2016;32:313-320. doi: 10.6515/acs20151013a.488475927274172
- 27. Soylu K, Gedikli Ö, Ekşi A, et al. Neutrophil-to-lymphocyte ratio for the assessment of hospital mortality in patients with acute pulmonary embolism. Arch Med Sci. 2016;1:95-100. doi: 10.5114/aoms.2016.57585.475437026925123
- 28. Ma Y, Mao Y, He X, Sun Y, Huang S, Qiu J. The values of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in predicting 30 day mortality in patients with acute pulmonary embolism. BMC Cardiovasc Disord. 2016;16:123. doi: 10.1186/s12872-016-0304-5.489329127259553
- 29. Kasapoğlu US, Olgun Yıldızeli Ş, Arıkan H, et al. Comparison of neutrophil to lymphocyte ratio with other prognostic markers affecting 30 day mortality in acute pulmonary embolism. Tuberk Toraks. 2019;67:179-189. doi: 10.5578/tt.68519.31709949
- 30. Phan T, Brailovsky Y, Fareed J, Hoppensteadt D, Iqbal O, Darki A. Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios Predict All-Cause Mortality in Acute Pulmonary Embolism. Clin Appl Thromb Hemost. 2020;26:1076029619900549. doi: 10.1177/1076029619900549.709820631960711
- 31. Efros O, Beit Halevi T, Meisel E, et al. The Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Patients Hospitalized with Acute Pulmonary Embolism. Journal of Clinical Medicine. 2021;10:4058. doi: 10.3390/jcm10184058.846950034575170
- 32. Duman D, Sonkaya E, Yıldırım E, et al. Association of Inflammatory Markers with Mortality in Patients Hospitalized with Non-massive Pulmonary Embolism. Turk Thorac J. 2021;22:24-30. doi: 10.5152/TurkThoracJ.2021.190076.791942633646100
- 33. Palareti G, Cosmi B, Legnani C, et al. D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study. Blood. 2014;124:196-203. doi: 10.1182/blood-2014-01-548065.24879813
- 34. Alonso-Martínez JL, Annicchérico-Sánchez FJ, Urbieta-Echezarreta MA, Pérez-Ricarte S. N-terminal Pro-B type natriuretic peptide as long-term predictor of death after an acute pulmonary embolism. Medicina Clínica. 2015;144:241-246. doi: 10.1016/j.medcli.2013.11.041.24947203
- 35. Weekes AJ, Johnson AK, Troha D, Thacker G, Chanler-Berat J, Runyon M. Prognostic Value of Right Ventricular Dysfunction Markers for Serious Adverse Events in Acute Normotensive Pulmonary Embolism. J Emerg Med. 2017;52:137-150. doi: 10.1016/j.jemermed.2016.09.002.27751702
- 36. Cavuş UY, Yildirim S, Sönmez E, Ertan C, Ozeke O. Prognostic value of neutrophil/lymphocyte ratio in patients with pulmonary embolism. Turk J Med Sci. 2014;44:50-55.10.3906/sag-1302-47